Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
1 Views
administrator
07/29/23
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
-
Category
Show more
Facebook Comments
No comments found